Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest Income - NetInterest Income - TotalNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Wages, Salaries and Other
Others
Ratios

Design Therapeutics (DSGN) Revenue (2020)

Design Therapeutics' Revenue history spans 1 years, with the latest figure at $33000.0 for Q4 2020.

  • On a quarterly basis, Revenue changed N/A to $33000.0 in Q4 2020 year-over-year; TTM through Dec 2020 was $226000.0, a N/A change, with the full-year FY2020 number at $226000.0, changed N/A from a year prior.
  • Revenue hit $33000.0 in Q4 2020 for Design Therapeutics, up from $20000.0 in the prior quarter.
  • Over the last five years, Revenue for DSGN hit a ceiling of $142000.0 in Q1 2020 and a floor of $20000.0 in Q3 2020.